Integration of new or experimental treatment options and new approaches to clinical trials

被引：3

作者：

Quinn, M

Pfisterer, J

Avall-Lundqvist, E

Bookman, M

Bowtell, D

Casado, A

Cervantes, A

Grenman, S

Harper, P

Oza, A

Pecorelli, S

Pujade-Lauraine, E

Trimble, E

Vasey, P

Wagner, U

机构：

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷

关键词：

D O I：

10.1093/annonc/mdi964

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：30 / 35

页数：6

相关论文

共 27 条

[11] Maintenance treatment with interferon for advanced ovarian cancer: results of the Northern and Yorkshire gynaecology group randomised phase III study [J].

Hall, GD ;

Brown, JM ;

Coleman, RE ;

Stead, M ;

Metcalf, KS ;

Peel, KR ;

Poole, C ;

Crawford, M ;

Hancock, B ;

Selby, PJ ;

Perren, TJ .

BRITISH JOURNAL OF CANCER, 2004, 91 (04) :621-626

[12]

Hirte H.W, 2001, P AN M AM SOC CLIN, V20, p211a

[13] A randomized trial of five versus eight courses of cisplatin or carboplatin in advanced epithelial ovarian carcinoma - A North Thames Ovary Group Study [J].

Lambert, HE ;

Rustin, GJS ;

Gregory, WM ;

Nelstrop, AE .

ANNALS OF ONCOLOGY, 1997, 8 (04) :327-333

[14] Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial [J].

Markman, M ;

Liu, PY ;

Wilczynski, S ;

Monk, B ;

Copeland, LJ ;

Alvarez, RD ;

Jiang, C ;

Alberts, D .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2460-2465

[15] Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study [J].

Ozols, RF ;

Bundy, BN ;

Greer, BE ;

Fowler, JM ;

Clarke-Pearson, D ;

Burger, RA ;

Mannel, RS ;

DeGeest, K ;

Hartenbach, EM ;

Baergen, R .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3194-3200

[16]

PFISTERER J, 2003, P AN M AM SOC CLIN, V22, P446

[17] Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy [J].

Piccart, MJ ;

Floquet, A ;

Scarfone, G ;

Willemse, PHB ;

Emerich, J ;

Vergote, I ;

Giurgea, L ;

Coens, C ;

Awada, A ;

Vermorken, JB .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 :196-203

[18]

SABBATINI P, 2004, P AM SOC CLIN ONCOL, V22

[19]

SCARFONE G, 2002, P AN M AM SOC CLIN, V21, pA204

[20]

SCHILDER RJ, 2003, P AN M AM SOC CLIN, V22, P451